Linda B. Cottler Receives Rema Lapouse Award for Contributions to Epidemiology and Control of Mental Disorders
The Mental Health, Epidemiology and Applied Statistics sections of the American Public Health Association have selected Linda B. Cottler, Ph.D., M.P.H., FACE, for the Rema Lapouse Award for Achievement in Epidemiology, Mental Health and Applied Public Health Statistics.
Headgear Significantly Reduces Girls’ Lacrosse Concussions, Landmark UF Health Study Finds
Female high school lacrosse players are significantly less likely to sustain concussions and other injuries if they wear headgear, a landmark study led by University of Florida Health researchers has found.
UF Innovate | Accelerate Receives International Soft Landings Designation
UF Innovate | Accelerate is pleased to announce its two business incubators, Sid Martin Biotech and The Hub, have received an official “Soft Landings” designation from the International Business Innovation Association (InBIA) for supporting international companies moving to Florida.
Rain Neuromorphics Tapes Out Demo Chip for Analog AI
UF startup and UF Innovate | Accelerate graduate Rain Neuromorphics, which incubated at The Hub, has taped out a demonstration chip for its brain-inspired analog architecture that employs a 3D array of randomly-connected memristors to compute neural network training and inference at extremely low power.
AavantiBio Furthers Strategic Partnership With University of Florida To Research and Develop Next Generation Gene Therapy Capsids
UF startup and UF Innovate | The Hub resident AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, announced it is partnering with the University of Florida to research and develop next generation gene therapy capsids with the goal of creating safer, more effective, and tissue specific gene therapies.
UF Innovate | Accelerate: A New Name for UF’s Incubation Services
The University of Florida’s incubation services program has a new name – UF Innovate | Accelerate – to better unify its world-class business incubators, Sid Martin Biotech and The Hub, under one best-in-class program.
ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations
UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility.
Dialectic Therapeutics Announces First-in-Human Dose in Phase 1 Clinical Trial Evaluating DT2216, Its First Generation Antiapoptotic Protein Targeted Degradation (APTaD™) Compound, in Patients With Relapsed or Refractory Malignancies
UF startup Dialectic Therapeutics, Inc., a Texas-based clinical-stage biotechnology company focused on creating innovative new technologies to treat cancer, announced the dosing of the first patient in a first-in-human, dose-escalation Phase 1 trial evaluating DT2216, the first generation compound built using its proprietary and novel Antiapoptotic Protein Targeted Degradation (APTaD™) technology, in patients with relapsed or refractory solid tumor and hematologic malignancies.
Interview with Juan Tomás Hernani, CEO of SATLANTIS
Avión Revue, an international aviation news site, interviewed Hernani about his journey licensing the technology with the University of Florida and upcoming projects.
The 2021 Nobel Prize for Medicine Helps Unravel Mysteries About How the Body Senses Temperature and Pressure
Steven D. Munger, a professor and vice-chair of the Department of Pharmacology and Therapeutics and Director of the Center for Smell and Taste at the University of Florida, shares his thoughts regarding the recently announced Nobel Prize Laureates for Physiology or Medicine in The Conversation.
